A new paper by Harvard researchers, using records only recently made available by the Food and Drug Administration, explains how faulty cardiac devices that were recalled a few years ago got onto the market, shedding light on a little-known process used by manufacturers to alter medical devices without putting them through human trials.
The devicemakers' shortcut
Letter
to the
Editor
Send us a letter
Have an opinion about this story? Click here to submit a Letter to the Editor, and we may publish it in print.
Recommended for You
Sponsored Content